Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,028 GBX | -2.18% | -2.72% | +13.47% |
May. 28 | US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment | RE |
May. 28 | Amgen's Rare-Disease Treatment Biosimilar Bkemv Gets FDA Approval | DJ |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ASTRAZENECA PLC | Other Pharmaceuticals | -2.18% | -2.72% | +13.47% | +2.07% | +102.56% | 243B |
- Stock Market
- Equities
- AZN Stock
- Charts AstraZeneca PLC
- Relative Strength Chart